189 related articles for article (PubMed ID: 17951987)
1. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
Alt S; Mitchenall LA; Maxwell A; Heide L
J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
Wu P; Lawrence LE; Denbleyker KL; Barrett JF
Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
[TBL] [Abstract][Full Text] [Related]
5. Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments.
Kolarič A; Novak D; Weiss M; Hrast M; Zdovc I; Anderluh M; Minovski N
Future Med Chem; 2019 May; 11(9):935-945. PubMed ID: 31140866
[No Abstract] [Full Text] [Related]
6. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
[TBL] [Abstract][Full Text] [Related]
7. A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
Gruger T; Nitiss JL; Maxwell A; Zechiedrich EL; Heisig P; Seeber S; Pommier Y; Strumberg D
Antimicrob Agents Chemother; 2004 Dec; 48(12):4495-504. PubMed ID: 15561817
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases.
Black MT; Stachyra T; Platel D; Girard AM; Claudon M; Bruneau JM; Miossec C
Antimicrob Agents Chemother; 2008 Sep; 52(9):3339-49. PubMed ID: 18625781
[TBL] [Abstract][Full Text] [Related]
9. Coumarin inhibitors of gyrase B with N-propargyloxy-carbamate as an effective pyrrole bioisostere.
Periers AM; Laurin P; Ferroud D; Haesslein JL; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 2000 Jan; 10(2):161-5. PubMed ID: 10673102
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.
Tanaka M; Sato K; Kimura Y; Hayakawa I; Osada Y; Nishino T
Antimicrob Agents Chemother; 1991 Jul; 35(7):1489-91. PubMed ID: 1656864
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of differential activities of ofloxacin enantiomers.
Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
[TBL] [Abstract][Full Text] [Related]
13. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of novel gyrase inhibitors of the aminocoumarin class.
Anderle C; Stieger M; Burrell M; Reinelt S; Maxwell A; Page M; Heide L
Antimicrob Agents Chemother; 2008 Jun; 52(6):1982-90. PubMed ID: 18347114
[TBL] [Abstract][Full Text] [Related]
16. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
Flatman RH; Howells AJ; Heide L; Fiedler HP; Maxwell A
Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
[TBL] [Abstract][Full Text] [Related]
19. New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.
Zidar N; Tomašič T; Macut H; Sirc A; Brvar M; Montalvão S; Tammela P; Ilaš J; Kikelj D
Eur J Med Chem; 2016 Jul; 117():197-211. PubMed ID: 27100032
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
